0001193125-13-092046.txt : 20140303 0001193125-13-092046.hdr.sgml : 20140303 20130305174959 ACCESSION NUMBER: 0001193125-13-092046 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HYPERION THERAPEUTICS INC CENTRAL INDEX KEY: 0001386858 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611512713 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-745-7802 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 CORRESP 1 filename1.htm Acceleration Request by the Underwriters

March 5, 2013

VIA EDGAR AND FACSIMILE

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Attention:   

Jeffrey Riedler

Daniel Greenspan

Amy Reischauer

 

Re: Hyperion Therapeutics, Inc.

Registration Statement on Form S-1

Registration No. 333-186880

Ladies and Gentlemen:

In connection with the above-captioned Registration Statement, we wish to advise that on March 5, 2013, 1,210 copies of the Preliminary Prospectus dated March 5, 2013, were distributed to prospective underwriters, institutional investors and prospective dealers.

We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934.

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time on March 7, 2013, or as soon thereafter as practicable.

 

[Signature page follows]

Very truly yours,

LEERINK SWANN LLC

COWEN AND COMPANY, LLC

As Representatives of the

Prospective Underwriters

 

LEERINK SWANN LLC
By:   /s/ Brian Giraudo
 

 

  Name:   Brian Giraudo
   

 

  Title:   Managing Director
   

 

 

COWEN AND COMPANY, LLC
By:   /s/ Grant Miller
 

 

  Name:   Grant Miller
   

 

  Title:   Head of Equity Capital Markets
   

 

 

[Signature Page to Acceleration Request]